Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Enterprise Value (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Enterprise Value for 4 consecutive years, with -$6.4 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value fell 479.03% to -$6.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.4 million through Dec 2025, down 479.03% year-over-year, with the annual reading at -$6.4 million for FY2025, 479.03% down from the prior year.
  • Enterprise Value for Q4 2025 was -$6.4 million at bioAffinity Technologies, up from -$7.7 million in the prior quarter.
  • The five-year high for Enterprise Value was -$444706.0 in Q1 2025, with the low at -$13.5 million in Q3 2022.
  • Average Enterprise Value over 4 years is -$5.1 million, with a median of -$3.7 million recorded in 2023.
  • The sharpest move saw Enterprise Value surged 90.36% in 2024, then tumbled 858.65% in 2025.
  • Over 4 years, Enterprise Value stood at -$11.4 million in 2022, then soared by 75.28% to -$2.8 million in 2023, then soared by 60.83% to -$1.1 million in 2024, then crashed by 479.03% to -$6.4 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$6.4 million, -$7.7 million, and -$802835.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.